Clinical trial
INfluenza VaccInation To Mitigate typE 1 Diabetes (INVITED Trial)
NCT05585983 is registered in ClinicalTrials.gov with Aarhus University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- INfluenza VaccInation To Mitigate typE 1 Diabetes (INVITED Trial)
- Lead sponsor
- Aarhus University Hospital
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- December 14, 2022
- Completion date
- May 1, 2027
- Enrollment
- 100 (estimated)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.